Jun Luo

发表

Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four post-hoc Analyses of Randomized Clinical Trials

Wengen Zhu, Lin Huang, Fuwei Liu, 2022, Frontiers in Cardiovascular Medicine.

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis

Donghua Huang, Yuting Hu, Fuwei Liu, 2022, Frontiers in Cardiovascular Medicine.

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis

Yupei Zhang, Fuwei Liu, Jun Luo, 2022, Frontiers in Cardiovascular Medicine.

Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis

Jiang Li, Yusi Chen, Jun Luo, 2021, Canadian respiratory journal.

Dose apolipoprotein AV has influence on the regulation of fatty acids and triglyceride metabolism in cardiomyocyte in case of obesity.

Shuiping Zhao, Jiang Li, Jun Luo, 2015, International journal of cardiology.

ComparativeEfficacyandSafetyofTargetedTherapies forChronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis

Jiang Li, Yusi Chen, Jun Luo, 2021 .

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve

Yalin Cao, Fuwei Liu, Jun Luo, 2022, Frontiers in Cardiovascular Medicine.

Elevated plasma Pim‐1 and its clinical significance in patients with pulmonary arterial hypertension

Jiang Li, Yi Wang, B. Sheng, 2019, Clinical and experimental pharmacology & physiology.

Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose–Response Meta-Analysis of Prospective Studies

Wengen Zhu, Yalin Cao, Jianyong Ma, 2022, Frontiers in Cardiovascular Medicine.

Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease

Shuiping Zhao, Jiang Li, Jun Luo, 2015, European journal of gastroenterology & hepatology.

Pregnancy outcomes in patients with pulmonary arterial hypertension

Jiang Li, Jun Luo, Li Xu, 2020, Medicine.

Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study

Zheng Wang, Yuhui Zhang, F. Gao, 2021, American Journal of Cardiovascular Drugs.

Effect of statins therapy prior to percutaneous coronary intervention.

Tianzheng Yu, Jiang Li, Jun Luo, 2012, Journal of interventional cardiology.

Expression of ApoA5 and its function in the right ventricular failing and remodeling secondary to pulmonary hypertension

Yusi Chen, Jiang Li, Minzhi Ouyang, 2020, Journal of cellular physiology.

Differential serum lipid distribution in IPAH and CHD-PAH patients.

Yusi Chen, A. Rathinasabapathy, Jun Luo, 2021, Respiratory medicine.

a Retrospective Study

Jun Luo, Li Xu, Huafang Shi, 2014 .

Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism

Jiang Li, Yusi Chen, Jun Luo, 2022, Lipids in Health and Disease.

Transition from Bosentan to Ambrisentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

Yusi Chen, Jiang Li, Jun Luo, 2021, International journal of general medicine.

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study

E. Kotlyar, Yusi Chen, Jiang Li, 2022, Frontiers in Pharmacology.

Effects and mechanisms of apolipoprotein A-V on the regulation of lipid accumulation in cardiomyocytes

Jiang Li, Jiang Li, Jun Luo, 2018, Lipids in Health and Disease.

Impact of COPD or Asthma on the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis

Wengen Zhu, Jianyong Ma, Xiao Liu, 2022, Frontiers in Cardiovascular Medicine.

The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis

P. Yu, Jianyong Ma, Xiao Liu, 2023, Frontiers in Endocrinology.

Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy

Jiang Li, Yusi Chen, Jun Luo, 2023, BMC Pulmonary Medicine.

Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report

Jiang Li, Jun Luo, Sisi Chen, 2022, Frontiers in Pharmacology.

Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review

Jiang Li, Yusi Chen, Jun Luo, 2023, BJOG : an international journal of obstetrics and gynaecology.

Relationships between sexual function, mental health, and quality of life of female patients with pulmonary arterial hypertension associated with congenital heart disease

Wen Zhou, Ting Luo, Jun Luo, 2022, Pulmonary circulation.

Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension

Jiang Li, Yusi Chen, Jun Luo, 2023, Frontiers in molecular biosciences.

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

Jiang Li, Yusi Chen, Jun Luo, 2023, Frontiers in pharmacology.

Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.

Jiang Li, Yusi Chen, Jun Luo, 2023, Journal of Electrocardiology.

Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk strati�cation

Jun Luo, 2023 .

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy

Fuwei Liu, Jun Luo, Xin Gao, 2023, Frontiers in cardiovascular medicine.

Effect of statins therapy prior to percutaneous coronary intervention.

Tianzheng Yu, Jiang Li, Jun Luo, 2012, Journal of interventional cardiology.